MCID: CRY003
MIFTS: 41

Cryptosporidiosis malady

Categories: Rare diseases, Infectious diseases, Gastrointestinal diseases

Aliases & Classifications for Cryptosporidiosis

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 36MeSH, 35MedlinePlus, 2CDC, 65UMLS, 27ICD10, 29ICD9CM, 59SNOMED-CT, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Cryptosporidiosis:

Name: Cryptosporidiosis 10 45 47 12 51 36 35 2 65
Cryptosporidial Gastroenteritis 10 65
 
Infection by Cryptosporidium 10
Intestinal Cryptosporidiosis 10

Characteristics:

Orphanet epidemiological data:

51
cryptosporidiosis:
Inheritance: Not applicable; Prevalence: 1-9/100000 (United States); Age of onset: All ages; Age of death: normal life expectancy

Classifications:



External Ids:

Disease Ontology10 DOID:1733
ICD1027 A07.2
ICD9CM29 007.4
MeSH36 D003457
Orphanet51 1549
ICD10 via Orphanet28 A07.2
MESH via Orphanet37 D003457
UMLS via Orphanet66 C0010418
UMLS65 C0010418, C0520796

Summaries for Cryptosporidiosis

About this section
MedlinePlus:35 Cryptosporidiosis (crypto) is an illness caused by a parasite. the parasite lives in soil, food and water. it may also be on surfaces that have been contaminated with waste. you can become infected if you swallow the parasite. the most common symptom of crypto is watery diarrhea. other symptoms include dehydration weight loss stomach cramps or pain fever nausea vomiting most people with crypto get better with no treatment, but crypto can cause serious problems in people with weak immune systems such as in people with hiv/aids. to reduce your risk of crypto, wash your hands often, avoid water that may be infected, and wash or peel fresh fruits and vegetables before eating. centers for disease control and prevention

MalaCards based summary: Cryptosporidiosis, also known as cryptosporidial gastroenteritis, is related to paralytic ileus and spinal cord injury. An important gene associated with Cryptosporidiosis is SST (Somatostatin), and among its related pathways are Prion diseases and Cytokines and Inflammatory Response. The drug nitazoxanide has been mentioned in the context of this disorder. Affiliated tissues include lung, small intestine and breast, and related mouse phenotypes are immune system and homeostasis/metabolism.

Disease Ontology:10 A coccidiosis that involves a parasitic protozoan infection of the intestine of humans and a wide range of animals caused by Cryptosporidium species, through contaminated water and food, The symptoms include watery diarrhea, dehydration, weight loss, abdominal pain, fever, nausea and vomiting. Cryptosporidium infections have also been found in other digestive tract organs, the lungs, and conjunctiva. Immunocompromised persons are at greater risk of developing the infection.

CDC:2 Cryptosporidium is a microscopic parasite that causes the diarrheal disease cryptosporidiosis. Both the parasite and the disease are commonly known as "Crypto."

Wikipedia:68 Cryptosporidiosis, also known as crypto, is a parasitic disease caused by Cryptosporidium, a genus of... more...

Related Diseases for Cryptosporidiosis

About this section

Diseases related to Cryptosporidiosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 480)
idRelated DiseaseScoreTop Affiliating Genes
1paralytic ileus30.3SST, VIP
2spinal cord injury30.3SST, VIP
3asthma29.7CAT, CD79A, IL1A, VIP
4periodontal disease29.7IL1A, MBL2
5optic neuritis29.5CD4, CD79A, IL1A
6trachoma29.5CD79A, MBL2
7systemic lupus erythematosus29.1CAT, CD79A, CXCL10, MBL2
8cryptosporidiosis-chronic cholangitis-liver disease syndrome12.3
9cryptorchidism11.3
10weaver johnson syndrome10.4SST, VIP
11dentin sensitivity10.4SST, VIP
12inhibited male orgasm10.4SST, VIP
13osmotic diarrhea10.4SST, VIP
14birdshot chorioretinopathy10.4SST, VIP
15gastric gastrinoma10.4SST, VIP
16hemangioma of peripheral nerve10.4SST, VIP
17joint disorders10.4SST, VIP
18weill-marchesani syndrome10.3CD79A, SST
19anatomical narrow angle borderline glaucoma10.3CD79A, IL1A
20small intestine cancer10.3CD79A, SST
21leukemia10.3
22hemoglobinuria10.3CD4, SST
23lacrimal passage granuloma10.3CD79A, SST
24sternum lymphoma10.3CD79A, IL1A
25pancreatitis10.2
26pineal dysgerminoma10.2CD4, IL1A
27infiltrating bladder lymphoepithelioma-like carcinoma10.2CD79A, SST
28lung cancer10.2
29breast cancer10.2
30hepatitis10.2
31alpha-methylacyl-coa racemase deficiency10.2SST, VIP
32legionellosis10.2CD79A, IL1A
33thyroiditis10.2
34neuronitis10.2
35submandibular gland disease10.2CD4, IL1A
36malignant cornea melanoma10.1CD4, CD79A
37mixed mineral dust pneumoconiosis10.1CAT, IL1A
38ectopic thymus10.1CD4, CD79A
39ocular hypotension10.1CD4, CD79A
40mixed endometrial stromal and smooth muscle tumor10.1CD4, CD79A
41chronic closed-angle glaucoma10.1CD4, CD79A
42differentiating neuroblastoma10.1CD4, CD79A
43chronic hiccups10.1CD4, CD79A
44plasma protein metabolism disease10.1CD4, CD79A
45late congenital syphilis10.1CD4, CD79A
46pityriasis rosea10.1CD4, CD79A
47cd40 deficiency10.1CD4, CD79A
48lacrimal system cancer10.1CD79A, CXCL10
49juvenile spinal muscular atrophy10.1CD4, CD79A
50prostatitis10.1

Graphical network of the top 20 diseases related to Cryptosporidiosis:



Diseases related to cryptosporidiosis

Symptoms for Cryptosporidiosis

About this section

Drugs & Therapeutics for Cryptosporidiosis

About this section

Drugs for Cryptosporidiosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 35)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Miconazoleapproved, investigationalPhase 3, Phase 2302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
2
RifabutinapprovedPhase 35272559-06-96323490
Synonyms:
(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,18,20-trihydroxy-1'-isobutyl-14-methoxy-7,9,15,17,19,21,25-heptamethyl-5,10,26-trioxo-3,5,9,10-tetrahydrospiro[9,4-(epoxypentadeca[1,11,13]trienoimino)furo[2',3':7,8]naphtho[1,2-d]imidazole-2,4'-piperidin
(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6-16,18,20- TETRAHYDROXY-1'-ISOBUTYL-14-METHOXY-7,9,15,17,19,21,25- HEPTAMETHYLSPIRO(9,4-(EPOXYPENTADECA(1,11,13)TRIENIMINO)-2H- FURO(2',3':7,8)NAPHTH(1,2-D)IMIDAZOLE-2,4'-PIPERIDINE)- 5,10,26(3H,9H)-TRIONE,16-ACETATE
(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6-16,18,20-Tetrahydroxy-1'-isobutyl-14-methoxy-7,9,15,17,19,21,25-heptamethylspiro(9,4-(epoxypentadeca(1,11,13)trienimino)-2H-furo(2',3':7,8)naphth(1,2-d)imidazole-2,4'-piperidine)-5,10,26(3H,9H)-trione,16-acetate
1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin XIV
1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv
4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S
4-N-Isobutylspiropiperidylrifamycin S
4-N-isobutylspiropiperidylrifamycin S
72559-06-9
AC-19109
Alfacid
Ambap72559-06-9
Ansamicin
Ansamycin
Ansatipin
Ansatipine
Antibiotic LM 427
Assatipin
BRN 3584778
C07235
C46H62N4O11
CHEBI:45367
CHEMBL444633
CID6323490
CPD001227203
D00424
D017828
DB00615
DRG-0085
Grunenthal Brand of Rifabutin
HMS1571M20
HSDB 3577
 
Kenfarma Brand of Rifabutin
LM 427
LM-427
LM427
LS-143839
MLS000759428
MLS001061256
MolPort-005-938-065
Mycobutin
Mycobutin (TN)
Mycobutin (tn)
Mycobutin, Ansamycin, LM 427, Ansatipine, Rifabutin
NCGC00090762-01
Pfizer Brand of Rifabutin
Prestwick2_001109
RBT
RIFABUTIN
Rifabutin
Rifabutin (JAN/USP/INN)
Rifabutin Pfizer Brand
Rifabutin [USAN:BAN:INN]
Rifabutina
Rifabutina [Spanish]
Rifabutine
Rifabutine [French]
Rifabutinum
Rifabutinum [Latin]
S1741_Selleck
SAM002589970
SMR000466322
SMR001227203
Spiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2',3':7,8]naphth[1,2-d]imidazole-2,4'-piperidine]-5,10,26(3H,9H)-trione, 16-(acetyloxy)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptameth
UNII-1W306TDA6S
3
Nitazoxanideapproved, investigationalPhase 3, Phase 2, Phase 14555981-09-441684
Synonyms:
(2-((5-Nitro-2-thiazolyl)carbamoyl)phenyl)acetat
2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide
2-Acetyloxy-N-[(5-nitro-2-thiazolyl)]benzamide
2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate
55981-09-4
AC-1302
AC1L26A1
AC1Q5NVY
AZT + Nitazoxanide
Adrovet
Alinia
Alinia (TN)
BRN 1225475
C12H9N3O5S
CHEMBL1401
CID41684
CPD000466367
Colufase
Cryptaz
D02486
DB00507
Daxon
Daxon, Dexidex, Kidonax, Pacovanton, Paramix, Nitax, Zox, Nitazoxanide
EINECS 259-931-8
FT-0082459
HMS2051L04
Heliton
I14-6011
LS-144176
MLS000759492
MLS001424074
MolPort-002-042-244
N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester)
 
N-(5-Nitrothiazol-2-yl)salicylamide acetate ester
NCGC00090774-01
NCI60_034935
NCIMech_000843
NITAZOXANIDE
NSC 697855
NSC697855
Nitaxozanid
Nitaxozanide
Nitazoxanid
Nitazoxanida
Nitazoxanida [INN-Spanish]
Nitazoxanide (USAN/INN)
Nitazoxanide [USAN:INN]
Nitazoxanidum
Nitazoxanidum [INN-Latin]
Nodik
Omniparax
Oprea1_263587
Phavic-1
S1627_Selleck
SAM001246708
SBB068315
SMR000466367
STK395664
Salicylamide, N-(5-nitro-2-thiazolyl)- acetate (ester)
Salicylamide, N-(5-nitro-2-thiazolyl)-, acetate (ester)
Taenitaz
Tizoxanide Glucuronide
Tizoxanide glucuronide
UNII-SOA12P041N
ZINC03956788
[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate
azt+ nitazoxanide
o-(N-(5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate
4
AzithromycinapprovedPhase 3, Phase 1, Phase 232283905-01-555185, 53477736, 447043
Synonyms:
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-15-oxo-11-{[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-1-oxa-6-azacyclopentadecan-13-yl 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranoside
(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)13-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-1-oxa-6-azacyclopentadecan-15-one
1-Oxa-6-azacyclopentadecan-15-one, 13-((2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-,(2R-(2R*,3S*
121470-24-4
75199_FLUKA
83905-01-5
9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycin A
AC-16014
AC1L9KEG
Aritromicina
Azasite
Azenil
Azifast
Azigram
Azimakrol
Azithramycine
Azithromycin
Azithromycin & Tumor Necrosis Factor
Azithromycin (AIDS Initiative)
Azithromycin (anhydrous)
Azithromycin Dihydrate
Azithromycin Monohydrate
Azithromycin Sterile
Azithromycin dihydrate
Azithromycin plus Tumor Necrosis Factor
Azithromycine
Azithromycine [French]
Azithromycinum
Azithromycinum [Latin]
Azitrocin
Azitromax
Azitromicina
Azitromicina [Spanish]
Azitromin
Azythromycin
BIDD:GT0792
BRN 5387583
BSPBio_002285
Bio-0676
C38H72N2O12
CCRIS 1961
CHEBI:2955
CHEMBL529
CID447043
CP-62993
CP62,993
CPD000471864
DCH3
DRG-0104
 
DivK1c_000233
HMS1922G12
HMS2094M11
HMS500L15
HSDB 7205
Hemomycin
IDI1_000233
KBio1_000233
KBio2_000787
KBio2_003355
KBio2_005923
KBio3_001505
KBioGR_000731
KBioSS_000787
LS-1834
MLS001055353
MLS001066331
MLS001201763
MLS001304005
MLS001332499
MLS001332500
Misultina
MolPort-002-507-426
N,N-Dimethyl-4-amino-benzaldehyde
NCGC00090753-01
NCGC00090753-02
NINDS_000233
NSC643732
SAM002589961
SMR000471864
SPBio_001544
SPECTRUM1503679
Spectrum2_001582
Spectrum3_000653
Spectrum4_000186
Spectrum5_001867
Spectrum_000307
Sumamed
Tromix
UNII-JTE4MNN1MD
XZ-450
Z-Pak
ZIT
Zentavion
Zithromac
Zithromax
Zithromax IV
Zithromycin
Zitromax
Zitromax Avium 600
Zmas
Zmax
azithromycin
5
FluconazoleapprovedPhase 3, Phase 217186386-73-43365
Synonyms:
2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2,4-difluoro-,1-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL
2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol
2-(2,4-Difluoro-phenyl)-1,3-bis-[1,2,4]triazol-1-yl-propan-2-ol
2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-2-propanol
2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol
2-(2,4-Difluorophenyl)-1,3-di-1H-1,2,4-triazol-1-ylpropan-2-ol
2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol
86386-73-4
AC-428
AC1L1FRQ
AC1Q77FV
AKOS000280854
AbZ Brand of Fluconazole
Afungil
Alflucoz
Aliud Brand of Fluconazole
Alpharma Brand of Fluconazole
Apo Fluconazole
Apo-Fluconazole
Apotex Brand of Fluconazole
Armstrong Brand of Fluconazole
BIDD:GT0799
BRD-K05977355-001-02-6
BSPBio_003504
Baten
Beagyne
Bio-0041
Biocanol
Biozole
Biozolene
C13H12F2N6O
CCRIS 7211
CHEBI:46081
CHEMBL106
CID3365
CPD000471882
Canesoral
Canzol
Chemia Brand of Fluconazole
Cryptal
D00322
D015725
DB00196
DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER
DIFLUCAN IN SODIUM CHLORIDE 0.9%
DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
DRG-0005
Diflazon
Diflucan
Diflucan (TN)
Diflucan, Trican, Alfumet, Fluconazole
Dimycon
DivK1c_001030
Effik Brand of Fluconazole
Elazor
F0677
F8929_SIGMA
FCZ
FLCZ
Fluc Hexal
Flucazol
FlucoLich
Flucobeta
Fluconazol
Fluconazol AL
Fluconazol AbZ
Fluconazol Isis
Fluconazol Stada
Fluconazol [Spanish]
Fluconazol ratiopharm
Fluconazol von ct
Fluconazol-Isis
Fluconazol-ratiopharm
Fluconazole
Fluconazole & Bovine Lactoferrin
Fluconazole & Human recombinant granulocyte colony stimulating factor
Fluconazole & MC-510,011
Fluconazole & hGCSF
Fluconazole (JAN/USAN/INN)
Fluconazole [USAN:INN:BAN:JAN]
Fluconazole in combination with MGCD290
Fluconazole in dextrose 5% in plastic container
Fluconazole in sodium chloride 0.9%
Fluconazole in sodium chloride 0.9% in plastic container
Fluconazolum
Fluconazolum [Latin]
Flucostat
 
Flucytosine & Nyotran
Flucytosine & Nyotran(Liposomal Nystatin)
Flukezol
Flunazul
Flunizol
Fluzone
Forcan
Fuconal
Fungata
GL663142 & Fluconazole
HMS1922O10
HMS2090I20
HMS2093M21
HMS503M21
HSDB 7420
Hexal Brand of Fluconazole
I06-0069
IDI1_001030
KBio1_001030
KBio2_002134
KBio2_004702
KBio2_007270
KBio3_003009
KBioGR_000360
KBioSS_002134
KS-1059
LS-1858
Lavisa
Lesvi Brand of Fluconazole
Lichtenstein Brand of Fluconazole
Loitin
MLS001066394
MLS001165780
MLS001195645
MLS001304713
MLS001306492
Mack Brand of Fluconazole
MolPort-000-883-859
MolPort-002-885-825
Monicure
Mutum
NCGC00095089-01
NCGC00095089-02
NCGC00095089-04
NCGC00095089-05
NINDS_001030
Neofomiral
Oxifugol
Oxifungol
Pfizer Brand of Fluconazole
Pfleger Brand of Fluconazole
Pritenzol
S1331_Selleck
SAM002589905
SAT Brand of Fluconazole
SMR000471882
SPBio_001613
SPECTRUM1503975
STK619301
Silanes Brand of Fluconazole
Solacap
Spectrum2_001607
Spectrum3_001912
Spectrum4_000090
Spectrum5_001277
Spectrum_001654
Stada Brand of Fluconazole
Syscan
TL8005609
TPF
Triflucan
UK 49858
UK-49858
UK49858
UNII-8VZV102JFY
Vita Brand of Fluconazole
XMP.284 & Fluconazole
XMP.366 & Fluconazole
XMP.391 & Fluconazole
ZINC00004009
Zemyc
Zoltec
Zonal
betapharm Brand of Fluconazole
ct Arzneimittel Brand of Fluconazole
ct-Arzneimittel Brand of Fluconazole
fluconazole
nchembio.100-comp3
nchembio.65-comp15
ratiopharm Brand of Fluconazole
6Antifungal AgentsPhase 3, Phase 23015
7Anti-Infective AgentsPhase 3, Phase 2, Phase 117220
8Antiparasitic AgentsPhase 3, Phase 2, Phase 11854
9Antiprotozoal AgentsPhase 3, Phase 2, Phase 11730
10Antibiotics, AntitubercularPhase 35971
11Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 29988
12HormonesPhase 3, Phase 211748
13Cytochrome P-450 CYP2C9 InhibitorsPhase 3, Phase 2497
14Cytochrome P-450 Enzyme InhibitorsPhase 3, Phase 23036
15Anti-Bacterial AgentsPhase 3, Phase 2, Phase 19140
16Hormone AntagonistsPhase 3, Phase 210002
17Antitubercular AgentsPhase 31061
18
Paromomycinapproved, investigationalPhase 2, Phase 1291263-89-4, 7542-37-2165580
Synonyms:
(1R,2R,3S,4R,6S)-4,6-Diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside
(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol
7542-37-2
84420-34-8
AC1L4WW9
Aminosidin
Aminosidine
Aminosidine, sulfate
C00832
CHEMBL370143
CID165580
Catenulin
Crestomycin
D07467
DB01421
Estomycin
Human .alpha.-1-antitrypsin & Paromomyin
Humatin
Hydroxymycin
Hydroxymycin sulfate
MolPort-002-510-747
Monomycin a
NSC227228
Neomycin E
 
Neomycin e
O-2-Amino-2-deoxy-.alpha.-D-glucopyranosyl-(1->4)-O-[O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1->3)-.beta.D-ribofuranosyl(1->5)]-2-deoxy-D-streptamine
PA1-PA2-PA3-PA4
PAROMOMYCIN
PAROMOMYCIN I, AMMINOSIDIN, CATENULIN, CRESTOMYCIN, MONOMYCIN A, NEOMYCIN E
Paramomycin Sulfate
Paramomycin sulfate
Paramomycin sulphate
Paromomicina
Paromomycin (INN)
Paromomycin (TN)
Paromomycin (complex)
Paromomycin I
Paromomycin i
Paromomycin sulfate Rx346208
Paromomycine
Paromomycinum
Paucimycin
Paucimycinum
R 400
R-400
STOCK1N-08708
Zygomycin a1
catenulin
hATT & Paromomycin
paromomycin
19
FlucytosineapprovedPhase 2242022-85-73366
Synonyms:
2(1H)-Pyrimidinone, 4-amino-5-fluoro-)
2-Hydroxy-4-amino-5-fluoropyrimidine
2022-85-7
4-Amino-5-fluoro-2(1H)-pyrimidinone
4-Amino-5-fluoro-2-hydroxypyrimidine
4-Amino-5-fluoro-2-hyroxypyrimidine
4-Amino-5-fluoropyrimidin-2(1H)-one
46850_FLUKA
5-FC
5-Flucytosine
5-Fluorocystosine
5-Fluorocytosin
5-Fluorocytosine
5-Fluorocytosine-6-3H
5-Flurocytosine
5-fluoro cytosine
5987P
6-Amino-2-oxo-5-fluoropyrimidine
6-amino-5-fluoro-1H-pyrimidin-2-one
9074P
AB00513969
AC-11748
AC1L1FRT
AC1Q52OQ
AKOS004912683
AKOS005063821
Alcobon
Ancobon
Ancobon (TN)
Ancobon (tn)
Ancotil
Ancotyl
BPBio1_000956
BSPBio_000868
C4H4FN3O
CAS-2022-85-7
CHEBI:5100
CHEMBL1463
CID3366
CPD000059047
Cytosine, 5-fluoro- (6CI,7CI,8CI)
D00323
DB01099
EINECS 217-968-7
F0321
F6770_SIGMA
F7129_SIGMA
Flucitosina
 
Flucitosina [DCIT]
Flucystine
Flucytosin
Flucytosine
Flucytosine (JP15/USP/INN)
Flucytosine [USAN:INN:BAN:JAN]
Flucytosinum
Flucytosinum [INN-Latin]
Flucytosone
Fluocytosine
Fluorcytosine
Fluorocytosine
GL663142 & 4-Amino-5-fluoropyrimidin-2(1H)-one
GL663142 & 5FC
HMS1570L10
HMS2051M04
HMS2093J05
HSDB 3082
I07-0006
LS-59140
LT00771985
MLS000069463
MLS000759519
MLS001076503
MolPort-000-155-561
MolPort-001-774-493
MolPort-002-317-353
MolPort-003-990-777
NCGC00016599-01
NCI60_000093
NSC 103805
NSC103805
Prestwick0_000934
Prestwick1_000934
Prestwick2_000934
Prestwick3_000934
Ro 2-9915
Ro 29915 E/265601
Ro-2-9915
S1666_Selleck
SAM001246753
SMR000059047
SPBio_003037
STK292386
TL8001667
UNII-D83282DT06
WLN: T6MVNJ DZ EF
ZINC00896546
flucytosine
20Immunologic FactorsPhase 1, Phase 218483
21Adjuvants, ImmunologicPhase 1, Phase 21783
22AntimetabolitesPhase 29454
23Interleukin-12Phase 1, Phase 2125
24Angiogenesis InhibitorsPhase 1, Phase 23688
25Angiogenesis Modulating AgentsPhase 1, Phase 23611
26
LoperamideapprovedPhase 111253179-11-63955
Synonyms:
2-methoxyethyl1-methylethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
34552-83-5 (mono-hydrochloride)
4-(4-Chlorophenyl)-N,N-dimethyl-.alpha.,.alpha.-diphenyl-4-hydroxy-1-piperidinebutanamide
4-(4-Chlorophenyl)-N,N-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide
5-21-02-00379 (Beilstein Handbook Reference)
53179-11-6
AB00053697
AC1L1H38
AKOS000573892
Apo-Loperamide
BAS 01889668
BPBio1_000274
BRD-K61250553-001-02-9
BRD-K61250553-003-05-8
BRN 1558273
BSPBio_000248
BSPBio_001381
BSPBio_002769
Bio1_000082
Bio1_000571
Bio1_001060
Bio2_000101
Bio2_000581
C07080
C29H33ClN2O2
CAS-34552-83-5
CBiol_001796
CHEBI:162259
CHEBI:6532
CHEMBL841
CID3955
D08144
DB00836
Diamide (TN)
Diarr-Eze
DivK1c_000215
EINECS 258-416-5
HMS1791F03
HMS1989F03
HMS2089C13
IDI1_000215
IDI1_033851
Imodium A-D
Imodium A-D Caplets
Ioperamide
KBio1_000215
KBio2_000101
KBio2_000854
KBio2_002669
KBio2_003422
KBio2_005237
KBio2_005990
KBio3_000201
KBio3_000202
 
KBio3_001989
KBioGR_000101
KBioGR_001685
KBioSS_000101
KBioSS_000854
Kaopectate II
L000709
LS-114352
Lopac-L-4762
Lopac0_000708
Loperacap
Loperamid
Loperamida
Loperamida [INN-Spanish]
Loperamide
Loperamide (INN)
Loperamide Hydrochloride
Loperamide Monohydrochloride
Loperamide [INN:BAN]
Loperamide hydrochloride
Loperamidum
Loperamidum [INN-Latin]
Lopéramide
Maalox Anti-Diarrheal
MolPort-001-969-016
NCGC00015608-01
NCGC00015608-08
NCGC00016828-01
NCGC00024818-01
NCGC00024818-02
NCGC00024818-03
NCGC00024818-04
NCGC00024818-05
NINDS_000215
Nu-Loperamide
Oprea1_109220
PMS-Loperamide
Pepto Diarrhea Control
Prestwick0_000144
Prestwick1_000144
Prestwick2_000144
Prestwick3_000144
R-18553
Rho-Loperamide
SPBio_001816
SPBio_002187
ST095179
Spectrum2_001738
Spectrum3_001015
Spectrum4_001143
Spectrum5_001374
Spectrum_000374
Tocris-0840
UNII-6X9OC3H4II
loperamide
nchembio.559-comp8
nchembio.79-comp7
27VaccinesPhase 16085
28SpiramycinPhase 14
29AntidiarrhealsPhase 1112
30ImmunoglobulinsPhase 14477
31AntibodiesPhase 14477
32Whey ProteinNutraceuticalPhase 1185
33
Formaldehydeexperimental7350-00-0712
Synonyms:
Aldeide formica
Fannoform
Formaldehyde
Formalina
Formaline
Formalith
Formic aldehyde
Formol
 
Methaldehyde
Methanal
Methyl aldehyde
Methylene glycol
Methylene oxide
Oxomethane
Oxomethylene
Oxymethylene
Paraform
Paraformaldehyde
34Diclazuril2
35Ether52

Interventional clinical trials:

(show all 27)
idNameStatusNCT IDPhase
1Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal MeningitisCompletedNCT00976040Phase 4
2A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected PatientsCompletedNCT00002122Phase 3
3Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS PatientsTerminatedNCT00004986Phase 3
4A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3CompletedNCT00000771Phase 2
5A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by CryptosporidiumCompletedNCT00001081Phase 2
6Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected ChildrenCompletedNCT00055107Phase 1, Phase 2
7Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS PatientsTerminatedNCT00057486Phase 1, Phase 2
8Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal InfectionTerminatedNCT01562132Phase 2
9A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS PatientsCompletedNCT00002248Phase 1
10A Study of Letrazuril in the Treatment of AIDS-Related DiarrheaCompletedNCT00001018Phase 1
11A Study of Spiramycin in the Treatment of Patients With AIDS-Related DiarrheaCompletedNCT00000980Phase 1
12A Study of Nitazoxanide in the Treatment of AIDS-Related DiarrheaCompletedNCT00002444Phase 1
13Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other DrugsCompletedNCT00002328
14Transmission and the Respiratory Tract in CryptosporidiosisCompletedNCT00507871
15Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)CompletedNCT00002027
16A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDSCompletedNCT00002278
17Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised PatientsCompletedNCT00002062
18Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind StudyCompletedNCT00002082
19The Effectiveness of Cow's Milk Immune Globulin in the Treatment of AIDS-Related DiarrheaCompletedNCT00002264
20Field Studies of Amebiasis in BangladeshCompletedNCT02734264
21Cryptosporidiosis and Enteropathogens in BangladeshRecruitingNCT02764918
22Parasitic Infections of the Gastrointestinal TractRecruitingNCT00001162
23A Study to Evaluate the Use of Nitazoxanide to Treat CryptosporidiosisActive, not recruitingNCT00002158
24Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease EventsActive, not recruitingNCT01699841
25Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive DisordersActive, not recruitingNCT02105714
26Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in KenyaNot yet recruitingNCT01695304
27Treatment of Chronic Cryptosporidiosis in AIDS PatientsTerminatedNCT00001128

Search NIH Clinical Center for Cryptosporidiosis

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: cryptosporidiosis

Genetic Tests for Cryptosporidiosis

About this section

Anatomical Context for Cryptosporidiosis

About this section

MalaCards organs/tissues related to Cryptosporidiosis:

33
Lung, Small intestine, Breast, Bone, Brain, Endothelial, T cells

Animal Models for Cryptosporidiosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Cryptosporidiosis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053876.9CD4, CD79A, CXCL10, IL1A, MBL2, SST
2MP:00053766.2CAT, CD4, CD79A, CXCL10, IL1A, MBL2

Publications for Cryptosporidiosis

About this section

Articles related to Cryptosporidiosis:

(show top 50)    (show all 565)
idTitleAuthorsYear
1
Development of a Performance-Based Measure of Executive Functions in Patients with Schizophrenia. (26561862)
2015
2
Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development. (25053715)
2015
3
Postural stability in children with hemiplegia estimated for three postural conditions: standing, sitting and kneeling. (25677032)
2015
4
Oleuropein offers cardioprotection in rats with simultaneous type 2 diabetes and renal hypertension. (25097277)
2014
5
Everyday psychological functioning in children with unilateral cerebral palsy: does executive functioning play a role? (24392947)
2014
6
Multiple myeloma diagnosed secondary to analysis of a lytic bone lesion encountered during mohs micrographic surgery. (24021441)
2013
7
Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. (23363771)
2013
8
Mature posterior fossa teratoma mimicking infratentorial meningioma: a case report. (22030172)
2012
9
Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia. (21984193)
2012
10
Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis. (22832203)
2012
11
Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma. (22669451)
2012
12
SPAST mutations in Australian patients with hereditary spastic paraplegia. (23252998)
2012
13
A mechanistic model of nutritional control of protein synthesis in animal tissues. (19808042)
2010
14
Toward improving the diagnosis and the treatment of adolescent pelvic inflammatory disease in emergency departments: results of a brief, educational intervention. (20094001)
2010
15
Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors. (20015880)
2010
16
Effect of Chinese herbal treatment on Th1- and Th2-type cytokines, progesterone and beta-human chorionic gonadotropin in early pregnant women of threatened abortion. (19802539)
2009
17
Excretory/secretory proteome of the adult developmental stage of human blood fluke, Schistosoma japonicum. (19299421)
2009
18
Identification of genes deregulated during serum-free medium adaptation of a Burkitt's lymphoma cell line. (18211290)
2008
19
Evaluation of functional single nucleotide polymorphisms of different genes coding for the immunoregulatory molecules in patients with monoclonal large granular lymphocyte lymphocytosis. (18361934)
2008
20
Chordoid meningioma: a report of two cases. (17517194)
2007
21
Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis. (17273808)
2007
22
Isoelectric points and post-translational modifications of connexin26 and connexin32. (16645047)
2006
23
The extent of right-to-left shunt fails to correlate with severity of clinical picture in migraine with aura. (16688594)
2006
24
Magnetic resonance imaging of effusive constrictive pericarditis. (16521660)
2005
25
The sealing effects of three desensitizers on tubule:an SEM investigation]. (15747014)
2005
26
Cysteine residues in the human cannabinoid receptor: only C257 and C264 are required for a functional receptor, and steric bulk at C386 impairs antagonist SR141716A binding. (15952782)
2005
27
Diagnostic importance of 3D CT images in Klippel-Feil Syndrome with multiple skeletal anomalies: a case report. (16374086)
2005
28
GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese. (16235982)
2005
29
Biology and pathology of nectins and nectin-like molecules. (15363801)
2004
30
The relationship between transplacental O2 diffusion and placental expression of PlGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction. (12740423)
2003
31
Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. (12647816)
2003
32
Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. (12569017)
2003
33
Development of a portable bruxism monitoring and analysis device equipped with a microcomputer and its practical application. (12735429)
2002
34
Relationship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients. (11522869)
2001
35
Hepatitis B virus infection and the response to erythropoietin in end-stage renal disease. (11575840)
2001
36
Enhanced expression of haem oxygenase-1 by nitric oxide and antiinflammatory drugs in NIH 3T3 fibroblasts. (10780998)
2000
37
Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. (10533580)
1999
38
Evaluation of the effectiveness of antihypertensive therapy. Is the trough-peak ratio the determining factor?]. (8686181)
1996
39
Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma. (8649545)
1996
40
Absence of mutations in the WT1 gene in patients with XY gonadal dysgenesis. (7607640)
1995
41
Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. (7513016)
1994
42
Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1. (7679712)
1993
43
The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. (8360389)
1993
44
The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34. (2370860)
1990
45
Crepitation simulating gas gangrene. A case report. (3980513)
1985
46
A monocytic leukemoid reaction: a manifestation of preleukemia. (3858941)
1985
47
Necropsy study of the olfactory portal of entry in herpes simplex encephalitis. (6100934)
1983
48
Photoprotection in erythropoietic protoporphyria: mechanism of photoprotection by beta carotene. (839088)
1977
49
An approach to metastatic nephroblastoma. (4346274)
1973
50

Variations for Cryptosporidiosis

About this section

Expression for genes affiliated with Cryptosporidiosis

About this section
Search GEO for disease gene expression data for Cryptosporidiosis.

Pathways for genes affiliated with Cryptosporidiosis

About this section

GO Terms for genes affiliated with Cryptosporidiosis

About this section

Biological processes related to Cryptosporidiosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1response to vitamin DGO:00332809.3CD4, CXCL10
2immune responseGO:00069558.8CD4, CXCL10, IL1A

Molecular functions related to Cryptosporidiosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1receptor bindingGO:00051028.8CXCL10, MBL2, VIP

Sources for Cryptosporidiosis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet